multiparametric mri software livermultiscan tm (Perspectum Diagnostics Ltd)
Structured Review

Multiparametric Mri Software Livermultiscan Tm, supplied by Perspectum Diagnostics Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiparametric+mri+software+livermultiscan+tm/multiparametric+mri/pmc10571783-28-18-20
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "The Role of the Multiparametric MRI LiverMultiScan TM in the Quantitative Assessment of the Liver and Its Predicted Clinical Applications in Patients Undergoing Major Hepatic Resection for Colorectal Liver Metastasis"
Article Title: The Role of the Multiparametric MRI LiverMultiScan TM in the Quantitative Assessment of the Liver and Its Predicted Clinical Applications in Patients Undergoing Major Hepatic Resection for Colorectal Liver Metastasis
Journal: Cancers
doi: 10.3390/cancers15194863
Figure Legend Snippet: LiverMultiScan TM schematic demonstration of the increasing degrees of liver disease activity/fibrosis (as measured by cT1 score) and liver fat content (as measured using PDFF) in 3 patients included in the Precision1 trial. Scores are graphically represented on an increasing colour scale on the liver. Images reproduced with permission from the Basingstoke Unit and Perspectum ltd.
Techniques Used: Activity Assay
Figure Legend Snippet: Summary of the potential future applications of the LiverMultiScan TM during the neoadjuvant, pre-habilitation, and peri-operative setting, as well as additional applications throughout the patient journey in order to improve post-operative outcomes. (CRLM = Colorectal Liver Metastasis, CALI = Chemotherapy associated liver injury, FLR = Future liver remnant, PHLF = Post hepatic liver failure).
Techniques Used:
Figure Legend Snippet: Pertinent current and future studies investigating the role of LiverMultiScan in Hepatic surgery for CRLM.
Techniques Used: Imaging, Modification, Diagnostic Assay, Biomarker Discovery, Clinical Proteomics, Sequencing, Histopathology, Software, Derivative Assay